Log on / register
Feedback | Support | My details
Deciphering cellular states of innate tumor drug responses.
Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Grémy G, Couillault C, Lajémi M, Piatier-Tonneau D, Zaborski P, Eveno E, Auffray C, Imbeaud S
Genome Biol 2006, 7:R19
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Molecular concepts analysis links tumors, pathways, mechanisms, and drugs.
Rhodes DR, Kalyana-Sundaram S, Tomlins SA, Mahavisno V, Kasper N, Varambally R, Barrette TR, Ghosh D, Varambally S, Chinnaiyan AM
Neoplasia 2007 May, 9:443-54
[PubMed Central] [PubMed] [Related articles]

2.
Dysadherin: a new player in cancer progression.
Nam JS, Hirohashi S, Wakefield LM
Cancer Lett 2007 Oct 8, 255:161-9
[PubMed Central] [PubMed] [Related articles]

3.
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor.
Turner NC, Lord CJ, Iorns E, Brough R, Swift S, Elliott R, Rayter S, Tutt AN, Ashworth A
EMBO J 2008 May 7, 27:1368-77
[PubMed Central] [PubMed] [Related articles]

4.
A functional and regulatory network associated with PIP expression in human breast cancer.
Debily MA, Marhomy SE, Boulanger V, Eveno E, Mariage-Samson R, Camarca A, Auffray C, Piatier-Tonneau D, Imbeaud S
PLoS One 2009, 4:e4696
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 5 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.